| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/03/1998 | US5714580 Trypsin Inhibitors |
| 02/03/1998 | US5714514 2-Cyano-3-mercaptocrotonamides |
| 02/03/1998 | US5714508 Inhibitors of angiotensin ii |
| 02/03/1998 | US5714504 Alkaline salts of omeprazole; antiulcer agents; magnesium omeprazole or sodium omeprazole for example |
| 02/03/1998 | US5714487 2,7-substituted octahydro-pyrrolo 1,2-a!pyrazine derivatives |
| 02/03/1998 | US5714486 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5713852 Oral dosage and method for treating painful conditions of the oral cavity |
| 02/03/1998 | CA2098989C Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 01/29/1998 | WO1998003547A1 Antagonists of intestinotrophic glp-2 peptides |
| 01/29/1998 | WO1998003516A1 Phosphinate based inhibitors of matrix metalloproteases |
| 01/29/1998 | WO1998003507A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | WO1998003502A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 01/29/1998 | WO1998003173A1 Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
| 01/29/1998 | WO1998003067A1 S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| 01/29/1998 | DE19630390A1 Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung Proteins, especially membrane proteins from Helicobacter pylori, their preparation and use |
| 01/29/1998 | CA2260990A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/28/1998 | EP0821061A2 Calcitonin gene-related peptide receptor component factor (houdc44) |
| 01/28/1998 | EP0820507A1 Ndf peptides |
| 01/28/1998 | EP0820455A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES |
| 01/28/1998 | EP0820445A1 Inhibitors of farnesyl-protein transferase |
| 01/28/1998 | EP0820444A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors |
| 01/28/1998 | EP0820434A1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives |
| 01/28/1998 | EP0820306A1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent |
| 01/28/1998 | EP0820292A1 Inhibition of c. difficile infections by indigestible oligosaccharides |
| 01/28/1998 | EP0752886B1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/28/1998 | CN1171780A Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 01/28/1998 | CN1171743A Novel tumor suppressor gene HIC-1 |
| 01/28/1998 | CN1171741A Freeze-dried ondanstetron compositions |
| 01/28/1998 | CN1171243A Antidiarrheal powder and producing process |
| 01/28/1998 | CN1171237A Intestinal juice quantity regulating agent |
| 01/28/1998 | CN1037148C Stable oral zinc compound |
| 01/27/1998 | US5712397 Amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds |
| 01/27/1998 | US5712312 Melatoninergic receptor ligands, treatment of sleep disorders |
| 01/27/1998 | US5712303 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity |
| 01/27/1998 | US5712300 Hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation |
| 01/27/1998 | US5712293 Gastrointestinal disorders |
| 01/27/1998 | US5712292 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/27/1998 | US5712291 Methods and compositions for inhibition of angiogenesis |
| 01/27/1998 | US5712273 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds |
| 01/27/1998 | US5712253 Macrocyclic 13-membered ring derivatives of erythromycins A and B |
| 01/27/1998 | US5712249 Use of insulin-like growth factors I and II for inhibition of inflammatory response |
| 01/27/1998 | US5711944 Interferon polymer conjugates |
| 01/22/1998 | WO1998002151A2 Chemokine receptor antagonists and methods of use therefor |
| 01/22/1998 | WO1998002144A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | WO1998002136A1 Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
| 01/22/1998 | CA2260284A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | CA2259927A1 Chemokine receptor antagonists and methods of use therefor |
| 01/21/1998 | EP0819380A1 Bacteriocidal, antibacterial and bacteriostatic composition |
| 01/21/1998 | EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/21/1998 | EP0819004A1 Pharmaceutical composition containing proton pump inhibitors |
| 01/21/1998 | EP0819001A1 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders |
| 01/21/1998 | EP0594636B1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
| 01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
| 01/21/1998 | CN1171113A Mutants of Rb and p53 genes and uses thereof |
| 01/21/1998 | CN1171109A Novel quinuclidine derivatives and medicinal composition thereof |
| 01/21/1998 | CN1170598A Gastric medicine |
| 01/21/1998 | CN1170591A External application medicinal bag for curing acute and chronic cholecystitis and its producing method |
| 01/21/1998 | CN1170580A Chinese drug composition for curing periodontitis |
| 01/20/1998 | US5710169 Therapeutic heterocycles |
| 01/20/1998 | US5710140 Phenyl heterocycles as COX-2 inhibitors |
| 01/20/1998 | US5710132 Use of bovine colostral milk as a preparation for the protection of the liver |
| 01/20/1998 | US5710127 Use of growth factor IGF-I and/or IGF-II |
| 01/20/1998 | US5710035 Human elastase IV |
| 01/20/1998 | US5710024 Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44) |
| 01/20/1998 | US5709995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 01/20/1998 | US5709888 High fat nutritional formula for infants and adults |
| 01/20/1998 | US5709860 Induction of cytotoxic T-lymphocyte responses |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001146A1 Preventives/remedies for stomatitis |
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | WO1998001143A1 Use of artichoke (cynara) extracts |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1998 | EP0818442A2 Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor |
| 01/14/1998 | EP0817864A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817782A1 Phenyl derivatives useful as endothelin receptor antagonists |
| 01/14/1998 | EP0817772A1 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 01/14/1998 | EP0817770A1 Nonpeptides as tachykinin antagonists |
| 01/14/1998 | EP0817646A2 Methods of treating inflammation and compositions therefor |
| 01/14/1998 | EP0817634A1 Azathioprine compositions for colonic administration |
| 01/14/1998 | EP0817631A2 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
| 01/14/1998 | EP0674639B1 Azanoradamantanes |
| 01/14/1998 | EP0661987B1 Morphogen-induced liver regeneration |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | EP0480052B1 Quinoline derivative, antiulcer drug containing the same, and production of said derivative |
| 01/14/1998 | CN1170356A Aerosol drug formulations |
| 01/14/1998 | CN1170340A Silicone compositions |
| 01/14/1998 | CN1169866A Medicine for chelicystitis |
| 01/14/1998 | CN1169862A Chinese medicine preparation for stomatocace |
| 01/14/1998 | CN1169859A Medicine for toothache |
| 01/13/1998 | US5708174 Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists |
| 01/13/1998 | US5708037 Inhibitor of inflammatory cytokine formation comprising polyprenyl derivatives as the active ingredient |
| 01/13/1998 | US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/13/1998 | US5708021 Debittered ranitidine preparation |
| 01/13/1998 | US5708017 Omeprazole pastes with thickeners |
| 01/13/1998 | US5708016 Pseudopeptides derived from neurokinins |